Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.

Arthritis & Rheumatology
Ji Yeon LeeSung-Hwan Park

Abstract

To evaluate associations of genetic polymorphisms in cytochrome P450 (CYP) isoforms 2D6, 3A5, and 3A4 with blood concentrations of hydroxychloroquine (HCQ) and its metabolite, N-desethyl HCQ (DHCQ), in patients with systemic lupus erythematosus (SLE). SLE patients taking HCQ for >3 months were recruited and were genotyped for 4 single-nucleotide polymorphisms in CYP2D6*10, CYP3A5*3, and CYP3A4*18B. Blood HCQ and DHCQ concentrations ([HCQ] and [DHCQ]) were measured and their association with corresponding genotypes was investigated. A total of 194 patients were included in the analysis. CYP2D6*10 polymorphisms (rs1065852 and rs1135840) were significantly associated with the [DHCQ]:[HCQ] ratio after adjustment for age, sex, dose per weight per day, and SLE Disease Activity Index score (P = 0.03 and P < 0.01, respectively). In adjusted models, the [DHCQ]:[HCQ] ratio was highest in patients with the G/G genotype of the CYP2D6*10 (rs1065852) polymorphism and lowest in those with the A/A genotype (P = 0.03). Similarly, the [DHCQ]:[HCQ] ratio was highest in patients with the C/C genotype of the CYP2D6*10 (rs1135840) polymorphism and lowest in those with the G/G genotype (P < 0.01). The CYP2D6*10 (rs1065852) polymorphism was significan...Continue Reading

References

Dec 1, 1992·Trends in Pharmacological Sciences·S CholertonJ R Idle
Feb 1, 1992·Journal of Pharmaceutical Sciences·S E TettR O Day
Jan 17, 1991·The New England Journal of Medicine·UNKNOWN Canadian Hydroxychloroquine Study Group
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
May 8, 1999·British Journal of Clinical Pharmacology·T FukudaJ Azuma
Feb 20, 2002·British Journal of Clinical Pharmacology·Leif BertilssonAyman Al-Shurbaji
Jul 13, 2002·Arthritis and Rheumatism·Tino MunsterDaniel E Furst
Jul 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·J Andrew WilliamsSteven A Wrighton
Sep 14, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ina KochLeszek Wojnowski
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
May 21, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Denis ProjeanJulie Ducharme
Sep 12, 2003·Archives of Pharmacal Research·Kyoung-Ah KimSabina Lim
Nov 26, 2003·Therapeutic Drug Monitoring·Samantha J CarmichaelSusan E Tett
Dec 26, 2003·Human Mutation·Hiromi Fukushima-UesakaJun-ichi Sawada
May 4, 2004·Best Practice & Research. Clinical Rheumatology·E TanakaN Kamatani
Jan 12, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Young Mi KimIn Ja Son
Feb 9, 2007·Pharmacogenomics·J P Gil, E Gil Berglund
Nov 1, 2007·Dermatologic Therapy·Sunil Kalia, Jan P Dutz
Apr 15, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Su-Jun LeeJae-Gook Shin
Oct 10, 2009·The American Journal of Tropical Medicine and Hygiene·Sei Won LeeInho Park
Jan 20, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chang-Woo YeoJae-Gook Shin
Aug 10, 2011·Nature Reviews. Rheumatology·Lesley Davila, Prabha Ranganathan
Feb 1, 2012·Expert Opinion on Drug Metabolism & Toxicology·Joseph McGraw, Donald Waller
Mar 15, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Anna K FüzéryWilliam A Clarke

❮ Previous
Next ❯

Citations

Mar 20, 2016·Ophthalmology·Michael F MarmorUNKNOWN American Academy of Ophthalmology
Jul 16, 2016·Expert Review of Clinical Immunology·Chi Chiu Mok
Apr 14, 2020·Ophthalmic Genetics·Heather G MackAnthony Jh Hall
Jun 6, 2020·JAMA Pediatrics·Anil R MaharajUNKNOWN Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee
May 20, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Rose H ManjiliMasoud H Manjili
May 10, 2020·British Journal of Clinical Pharmacology·Ahmet Emre Eşkazan
Aug 30, 2019·Cancer Chemotherapy and Pharmacology·Janice M MehnertMark N Stein
Sep 17, 2020·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Eleni KaratzaVangelis Karalis
Sep 27, 2018·Clinical Pharmacokinetics·Stephen J BalevicMichael Cohen-Wolkowiez
Sep 19, 2019·Arthritis & Rheumatology·Michelle PetriDaniel W Goldman
Sep 4, 2020·Vestnik oftalmologii·M V Budzinskaya, M H Durzhinskaya
Aug 31, 2020·NPJ Genomic Medicine·Takuto TakahashiPamala A Jacobson
Dec 1, 2017·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Cátia CunhaLiz Lightstone
Feb 9, 2020·Nature Reviews. Rheumatology·Eva Schrezenmeier, Thomas Dörner
Sep 10, 2020·Frontiers in Microbiology·Igor de Andrade SantosAna Carolina Gomes Jardim
Nov 3, 2015·The Journal of Rheumatology·Nathalie Costedoat-ChalumeauJean-Charles Piette
Apr 1, 2017·Journal of Genetics·Gurpreet KaurSandeep Singh
May 6, 2020·Antimicrobial Agents and Chemotherapy·Anne C G AlmeidaGisely C Melo
Sep 5, 2020·Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society·Allan GiriAshok K Giri
Aug 3, 2020·Arthritis & Rheumatology·Michelle PetriDaniel W Goldman
Feb 5, 2021·European Journal of Drug Metabolism and Pharmacokinetics·Subrata Deb, Scott Arrighi
Oct 31, 2020·Pharmacogenomics and Personalized Medicine·Mariana Babayeva, Zvi Loewy
May 19, 2020·Current Cancer Drug Targets·Hadeil M E IdrisAbozer Y Elderdery
Nov 24, 2020·American Journal of Ophthalmology·Lawrence Siu-Chun LawSiang Fei Yeoh
Feb 13, 2021·NPJ Genomic Medicine·Takuto TakahashiPamala A Jacobson
Jun 9, 2020·European Journal of Internal Medicine·Piero PortincasaAgostino Di Ciaula
Apr 4, 2021·Viruses·Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
Apr 18, 2020·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Pierre Ambrosi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.